Several specialized firms worldwide focus on the production of complex drug APIs, notably Abacavir sulfate, Abarelix, and Abiraterone Acetate. These compounds present significant hurdles in process development due to their structural intricacy. The suppliers of these APIs often employ advanced processes and adhere to strict compliance guidelines to